Czechia vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Treatment for hypertension, female

Czechia
68.2%
in 2019
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
48.1%
in 2019
Czechia rank
16th
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
18th

Treatment for hypertension, female over time

  • Czechia
  • Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
0204060199020042019

How they compare

Czechia currently reports 68.2% against 48.1% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 20.1%.

That makes Czechia's figure about 1.4 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.

Across all 30 years both countries report, Czechia has been ahead every year.

Czechia ranks 16th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th of 192 countries.

Czechia has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Czechia Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) Difference Ahead
1990s 48.4% 29.8% 18.6% Czechia
2000s 60.8% 40.0% 20.8% Czechia
2010s 67.2% 47.4% 19.7% Czechia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment for hypertension, female, Czechia or Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
Czechia, at 68.2% against 48.1% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2019.
What is the difference in treatment for hypertension, female between Czechia and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
20.1%, with Czechia ahead.
How many years of comparable data are there for Czechia and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
30 years are reported by both, from 1990 to 2019.
How do Czechia and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank globally for treatment for hypertension, female?
Czechia ranks 16th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th of 192 countries.
Where does this data come from?
World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, female (% of female adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Czechia vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Treatment for hypertension, female. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 18 September 2026, from https://health.statizoid.com/compare/treatment-for-hypertension-female-percent-of-female-adults-ages-30-79-with-hypertension/czechia/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-for-hypertension-female-percent-of-female-adults-ages-30-79-with-hypertension/czechia/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/">Czechia vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Treatment for hypertension, female</a> — Statizoid

About this data

Indicator
Treatment for hypertension, female (% of female adults ages 30-79 with hypertension)
Unit
% of female adults ages 30-79 with hypertension
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.